| |
DIAGNOSTIC NOTES
Update on porcine circovirus and postweaning multisystemic
wasting syndrome (PMWS)
Steven D. Sorden, DVM, PhD, Dipl ACVP
Sorden SD. Update on porcine circovirus and postweaning multisystemic
wasting syndrome (PMWS). Swine Health Prod. 2000;8(3):133-136.
This article is available in PDF format
(88K).
Veterinary Diagnostic Laboratory, Department of Veterinary
Diagnostic and Production Animal Medicine, College of Veterinary
Medicine, Iowa State University, Ames, Iowa 50011-1250; email:
ssorden@iastate.edu
This diagnostic note has been refereed.
Summary
Postweaning multisystemic wasting syndrome (PMWS) is a recently
emerged disease of nursery and grower pigs associated with type
2 porcine circovirus (PCV2) infection. A proposed case definition
of PMWS requires that a pig/group of pigs have all of the following:
1) clinical signs characterized by wasting/failure to thrive,
with or without dyspnea or icterus; 2) histologic lesions characterized
by depletion of lymphoid tissues and/or lymphohistiocytic to granulomatous
inflammation in any organ, typically lungs and/or lymphoid tissues;
and 3) PCV2 within characteristic lesions. Immunohistochemistry
and in situ hybridization applied to formalin-fixed tissues are
the preferred methods for demonstrating PCV2 antigen or genome,
respectively, within PMWS lesions. Since available evidence indicates
that PCV2 infection is much more common than PMWS, demonstrating
PCV2 exposure via serology or infection via isolation or PCR without
localizing PCV2 within characteristic lesions cannot constitute
a diagnosis of PMWS. To date, consistent experimental reproduction
of severe PMWS has only been accomplished via PCV2-parvovirus
or PCV2-PRRSV co-infection. Effective control of PMWS will require
an understanding of the viral and nonviral cofactors that enable
PCV2, an apparently ubiquitous and generally nonpathogenic agent,
to induce PMWS.
Keywords: swine, postweaning
multisystemic wasting syndrome (PMWS), porcine circovirus
Received: November 18, 1999
Accepted: March 2, 2000
Postweaning multisystemic
wasting syndrome (PMWS) was first reported in 1995-96 by Harding
and Clark.1,2 In 1997, these authors published a Diagnostic
Note in Swine Health and Production describing the
recognition and diagnosis of this syndrome.3 Since
that time, PMWS has been reported in swine-producing countries
worldwide, and much has been published about the syndrome and
porcine circovirus (PCV).4-10 The purpose of this paper
is to provide both a diagnostic update and a perspective from
the midwestern United States (Iowa) on PMWS and PCV.
Porcine circovirus (PCV)
Porcine circovirus is a very small (17 nm), nonenveloped, single-stranded
DNA virus. Type 1 PCV (PCV1) is a contaminant of the PK-15 cell
line that was first described over 20 years ago.11,12
Inoculation of cesarean-derived, colostrum-deprived pigs with
PCV1 results in viral replication but fails to induce lesions
or disease.12,13 Type 2 PCV (PCV2) is consistently
demonstrated in PMWS lesions and was first identified and characterized
in 1998.4-6,14 The serotype and genotype of PCV2 is
markedly different from that of PCV1.4-6,9,10,14 It
is currently uncertain whether the PCV that has been associated
with congenital tremors is PCV1 or PCV2.15
PMWS: Definition and diagnosis
Postweaning multisystemic wasting syndrome is a disease of
nursery and grower pigs that is characterized clinically by progressive
dyspnea and emaciation; diarrhea, pallor, and jaundice are less-consistent
clinical signs.3,16 Morbidity is typically 5%-15%.
Diagnosis of PMWS is based on demonstration of characteristic
histologic lesions, and these lesions consistently contain PCV2.4-6,9,10,14
Although a formal definition of PMWS has not been explicitly
stated, I submit that diagnosis of PMWS requires that a pig/group
of pigs exhibit all of the following:
- clinical signs: wasting/weight loss/ill thrift/failure to
thrive (Figure 1),
with or without dyspnea or icterus;
- histologic lesions: depletion of lymphoid organs/tissues
and/or lymphohistiocytic to granulomatous inflammation in any
organ (typically lungs and/or lymphoid tissues, and less often
liver, kidney, pancreas, intestine);
- PCV2 infection within characteristic lesions.
Note the following implications of this definition:
- Clinical signs are not diagnostic. There are many causes
of poor performance in nursery and grower pigs.3
- Gross lesions are not diagnostic. Although pigs with PMWS
typically have interstitial pneumonia, characterized by mottled
red and tan, rubbery, noncollapsed lungs, and moderate to severe
lymph-node enlargement (Figure
2), these lesions are nonspecific and are also found in other
diseases, especially porcine reproductive and respiratory syndrome
(PRRS) and septicemic salmonellosis. Furthermore, gross lesions
caused by concurrent bacterial and viral infections may modify/obscure
PMWS lesions.
- PCV2 infection PMWS. Both lesions and PCV2 must be
present to diagnose PMWS in a poorly performing pig.
Tissues to submit for diagnosis
Since diagnosis of PMWS requires the demonstration of PCV2
in histologic lesions, submission of formalin-fixed tissues to
a diagnostic laboratory is required; if PMWS diagnosis is the
only objective, then only formalin-fixed tissues need be submitted.
The preferred specimens are small portions of lung (three to four
samples), lymphoid tissues (tonsil, thymus, spleen, ileum [Peyer's
patch], enlarged lymph nodes), liver, kidney, and pancreas. Stomach,
duodenum, jejunum, and colon are also sometimes useful. If PCV2
isolation is desired, and/or to rule out other infectious agents,
chilled samples of fresh lung, tonsil, thymus, spleen, ileum,
enlarged lymph nodes, liver, and kidney should also be submitted.
Detecting PCV2 infection
Clusters of globular intracytoplasmic inclusion bodies are
frequently present in macrophages within PMWS lesions; these inclusions
are consistent with those found in circoviral diseases in other
species and were the first indication of a potential viral cause
of PMWS.1,3 When such inclusions are present and typical,
they are reliable indicators of PCV2 infection; however, in our
experience inclusions are present in less than half of PMWS cases,
and when present may vary considerably in morphology. For these
reasons, other methods are usually required to detect PCV2 infection.
Immunohistochemistry and in situ hybridization
Multiple methods have been developed to detect PCV2 infection.4-6,14,17-19
The sensitivity and specificity of most of these methods have
not been rigorously established or compared. Because diagnosing
PMWS requires demonstration of PCV2 within histologic lesions
(Figure 3), immunohistochemistry
(IHC) for PCV2 antigen or in situ hybridization (ISH) for PCV2
nucleic acid are the preferred diagnostic methods. Both of these
tests are performed on paraffin-embedded, formalin-fixed tissues.
Both polyclonal antisera and monoclonal antibodies have been used
for PCV2 IHC,4,7,17,20 and several groups have developed
ISH probes that detect PCV2 nucleic acid.5,6,17,18
In general, IHC is more rapid and economical than ISH; a recent
report indicates that ISH may detect more positive cells.17
Virus isolation
PCV2 infection has also been demonstrated via virus isolation
(VI)4,6,9,10 or polymerase chain reaction (PCR).6,14,19,21
Isolation of PCV2 is performed in PK-15 cells that are free of
PCV1 contamination. Virus isolation is time consuming and does
not appear to be as sensitive as IHC or ISH. However, PCV2 isolates
are currently desirable for research purposes and may someday
be of clinical value for typing (via nucleotide sequencing or
monoclonal antibody analysis) or possibly for the production of
autogenous vaccines.
Polymerase chain reaction
Polymerase chain reaction (PCR) assays that can differentiate
PCV1 and PCV2 have been developed,19 and PCR can thus
be used to type viral isolates; to date, all PCV isolates in our
laboratory have been type 2 (unpublished observation). Although
PCR may be used for the direct detection of PCV2 in tissues, it
is important to recognize that PCV2 infection can occur in the
absence of PMWS;21 we have observed PCV2 infection
in tonsils from healthy pigs obtained at slaughter (unpublished
observation). Furthermore, since circoviral particles are highly
resistant and likely to persist in the environment for extended
periods of time,22 the potential for PCV2 contamination
of tissues obtained in the field or the laboratory is high. Given
the apparent ubiquity and environmental stability of PCV2, it
is my opinion that PCR may be too sensitive to be useful for the
routine diagnosis of PMWS.
PCV2 serology
Indirect immunofluorescence assays (IIFA) have been developed
for both PCV1 and PCV2. Several reports indicate a high prevalence
of antibodies to PCV1.23-25 PCV2 seroprevalence is
also reported to be very high,5,26 and this is consistent
with our observations; we have been unable to identify a seronegative
swine herd. We recently tested sow serum from 28 high-health herds;
most sows in all of these herds were seropositive, but none reported
experiencing PMWS (Sorden SD, Halbur PG, Harms PA, unpublished
data). Serology is of little use in PMWS diagnosis but might
be of value in determining when in the late nursery or early finishing
phase seroconversion occurs in a given herd.
Diagnostic trends
At the Iowa State University Veterinary Diagnostic Laboratory,
PMWS/PCV2 infection was diagnosed in
- 16 herds in 1997,
- 111 herds in 1998, and
- 449 herds in 1999.
Most cases are in the late nursery/early grow-finish age groups,
and morbidity typically ranges from 5%-15%. Most cases have interstitial
pneumonia, and lung and lymphoid tissues are the most common sites
in which PCV2 infection is demonstrated (primarily by IHC). Porcine
reproductive and respiratory syndrome virus (PRRSV) is the most
common co-infecting agent, and is demonstrated (predominantly
by IHC) in over 60% of cases of PMWS; given the relative insensitivity
of IHC for diagnosing PRRSV infection, we suspect that the true
incidence of PRRSV and PCV2 co-infection is higher. This is in
contrast to the situation in western Canada, in which only approximately
20% of PMWS cases have evidence of concurrent PRRSV infection.27
Clark and Harding first identified PMWS in a western Canadian
herd in 1991.1,2 We recently performed a retrospective
study in which in situ hybridization for PCV2 was applied to archived
paraffin tissue blocks dating from 1993.28 Tissues
exhibiting lesions consistent with PMWS and containing abundant
PCV2 genome were identified in cases submitted as early as September
1993. Severe depletion of lymphoid tissues was associated with
high numbers of PCV2-containing cells within those tissues. Lung
lesions typically associated with high numbers of PCV2-containing
cells included severe lymphohistiocytic to granulomatous interstitial
pneumonia, and airway epithelial attenuation or erosion, as well
as partial obliteration of airway lumens by fibrous connective
tissue. Low numbers of PCV2-containing cells were typically
found within lymphoid follicles in tissues such as Peyer's patch,
tonsil, lymph node, or spleen that were histologically unremarkable.
Does PCV2 cause PMWS?
Lymphoid depletion and hepatic disease consistent with PMWS
have been reproduced in gnotobiotic or colostrum-deprived pigs
with inocula containing PCV2 and porcine parvovirus.7,8
To date, consistent reproduction of severe PMWS in the absence
of parvovirus co-infection has not been reported.29
We have reproduced severe interstitial pneumonia and other features
of PMWS by co-infecting cesarean-derived/colostrum-deprived pigs
with PCV2 and PRRSV.30 Although it is clear that PCV2
infection is necessary for the development of PMWS, it appears
that other factors, such as co-infecting viruses, are also required.
As noted above, sporadic cases of PMWS occurred as early as
1991 in western Canada and 1993 in the United States. Why PMWS
has emerged as a significant problem within the last 4-5 years
is uncertain. All available evidence indicates that PCV2 infection
is extremely common,5,16,21,26 yet only a minority
of infected herds (and pigs) develop PMWS. Whether different PCV2
isolates vary in virulence has not been determined. Additional
research will be required to explain the emergence of this new
syndrome and to identify the cofactors that enable PCV2, an apparently
ubiquitous and usually nonpathogenic agent, to induce PMWS.
References
4. Ellis J, Hazzard L, Clark E, Harding J, Allan G, et al.
Isolation of circovirus from lesions of pigs with post-weaning
multisystemic wasting syndrome. Can Vet J. 1998; 39:44-51.
5. Allan GM, McNeilly F, Kennedy S, Daft B, Clark EG, Ellis
JA, Haines DM, Meehan BM, Adair BM. Isolation of porcine circovirus-like
viruses from pigs with a wasting disease in the USA and Europe.
J Vet Diagn Invest. 1998; 10:3-10.
6. Morozov I, Sirinarumitr T, Sorden SD, Halbur PG, Morgan
MK, Yoon K-J, Paul PS. Detection of a novel strain of porcine
circovirus in pigs with postweaning multisystemic wasting syndrome
(PMWS). J Clin Microbiol. 1998; 36:2535-2541.
7. Ellis J, Krakowka S, Lairmore M, et al. Reproduction of
lesions of postweaning multisystemic wasting syndrome in gnotobiotic
piglets. J Vet Diagn Invest. 1999; 11:3-14.
8. Allan GM, Kennedy S, McNeilly F, et al. Experimental reproduction
of severe wasting disease by co-infection of pigs with porcine
circovirus and porcine parvovirus. J Comp Pathol. 1999;
121:1-11.
9. Meehan BM, McNeilly F, Todd D, Kennedy S, et al. Characterization
of novel circovirus DNAs associated with wasting syndromes in
pigs. J Gen Virol. 1998; 79:2171-2179.
10. Allan GM, Mc Neilly F, Meehan BM, et al. Isolation and
characterisation of circoviruses from pigs with wasting syndromes
in Spain, Denmark and Northern Ireland. Vet Microbiol.
1999; 66:115-123.
11. Tischer I, Gelderblom H, Vetterman W, Koch MA. A very small
porcine virus with circular single-stranded DNA. Nature.
1982; 295:64-66.
12. Tischer I, Mields W, Wolff D, Vagt M, Griem W. Studies
on epidemiology and pathogenicity of porcine circovirus. Arch
Virol. 1986;91:271-276.
13. Allan GM, McNeilly F, Cassidy JP, Reilly GAC, Adair B.
Pathogenesis of porcine circovirus, experimental infections of
colostrum deprived piglets and examination of pig fetal material.
Vet Microbiol. 1995; 44, 49-64.
14. Hamel AL, Lihua LL, Nayar GPS. Nucleotide sequences of
porcine circovirus associated with postweaning multisystemic wasting
syndrome in pigs. J Virol. 1998; 72:5262-5267.
16. Harding JCS, Clark
EG, Strokappe JH, Willson PI, Ellis JA. Postweaning multisystemic
wasting syndrome: Epidemiology and clinical presentation. Swine
Health Prod. 1998; 6:249-254
17. McNeilly F, Kennedy S, Moffett D, et al. A comparison of
in situ hybridization and immunohistochemistry for the detection
of a new porcine circovirus in formalin-fixed tissues from pigs
with post-weaning multisystemic wasting syndrome (PMWS). J
Virol Methods. 1999; 80:123-128.
18. Choi C, Chae C. In-situ hybridization for the detection
of porcine circovirus in pigs with postweaning multisystemic wasting
syndrome. J Comp Pathol. 1999; 121:265-270.
19. Larochelle R, Antaya M, Morin M, Magar R. Typing of porcine
circovirus in clinical specimens by multiplex PCR. J Virol
Methods. 1999; 80:69-75.
20. Sorden SD, Harms PA, Nawagitgul P, Cavanaugh D, Paul PS.
Development of a polyclonal-antibody-based immunohistochemical
method for the detection of type 2 porcine circovirus in formalin-fixed,
paraffin-embedded tissue. J Vet Diagn Invest. 1999; 11:528-530.
21. Larochelle R, Morin M, Antaya M, Magar R. Identification
and incidence of porcine circovirus in routine field cases in
Quebec as determined by PCR. Vet Rec. 1999; 145:140-142.
22. Allan JM, Phenix KV, Todd D, McNulty MS. Some biological
and physico-chemical properties of porcine circovirus. J Vet
Med B. 1994; 41:17-26.
23. Tischer I, Mields W, Wolff D, Vagt M, Greim W. Studies
on epidemiology and pathogenicity of porcine circovirus. Arch
Virol. 1986; 91:271-276.
24. Dulac GC, Afshar A. Porcine circovirus antigens in PK-15
cell line (ATCC CCL-33) and evidence of antibodies to circovirus
in Canadian pigs. Can J Vet Res. 1989;53:431-433.
25. Hines RK, Lukert
PD. Porcine circovirus: A serological survey of swine in the United
States. Swine Health Prod. 1995; 3:71-73.
27. Allan GM, Ellis JA. Porcine circoviruses: a review. J
Vet Diagn Invest. 2000; 12:3-14.
29. Balasch M, Segales J, Rosell C, et al. Experimental inoculation
of conventional pigs with tissue homogenates from pigs with post-weaning
multisystemic wasting syndrome. J Comp Pathol. 1999; 121:139-148.
References - nonrefereed
1. Clark EG. Post-weaning multisystemic wasting syndrome. Proc
AASP Ann Meet. 1997:499-501.
2. Harding JC. Post-weaning multisystemic wasting syndrome
(PMWS): Preliminary epidemiology and clinical presentation.
Proc AASP Ann Meet. 1997; 503.
3. Harding JCS, Clark
EG. Recognizing and diagnosing postweaning multisystemic wasting
syndrome (PMWS). Swine Health Prod. 1997; 5:201-203.
15. Hines RK, Lukert PD. Porcine circovirus as a cause of congenital
tremors in newborn pigs. Proc AASP Ann Meet. 1994; 344-345.
26. Harding JCS, Clark EG, Ellis JA. The clinical expression
of porcine circovirus. Proceedings, Allen D. Leman Swine Conference,
1999; 252-254.
28. Sorden SD, Thacker, BJ, Harms PA, Sirinarumitr T, Morozov
I, Paul PS. Retrospective study of porcine circovirus infection
in porcine tissues submitted to the Iowa State University Veterinary
Diagnostic Laboratory using in situ hybridization. Proc AAVLD
Ann Meet (abstract), October 1999.
30. Harms PA, Sorden SD, Halbur PG. Experimental reproduction
of severe disease in CD/CD pigs co-infected with PRRSV and type
2 porcine circovirus. Proc AASP Ann Meet. 2000; 325-326.
|
|